BPC-157: The Complete Evidence-Based Guide

BPC-157, or Body Protection Compound-157, is one of the most researched peptides in the field of regenerative medicine. It is a synthetic peptide derived from a protein found in human gastric juice, consisting of 15 amino acids.

Mechanism of action: BPC-157 exerts its effects through multiple pathways. It promotes angiogenesis (formation of new blood vessels), modulates nitric oxide synthesis, upregulates growth hormone receptor expression, and interacts with the dopaminergic and serotonergic systems. These combined effects make it particularly interesting for tissue repair research.

Preclinical research: The majority of BPC-157 research is animal-based. Studies in rodents have demonstrated accelerated healing of tendons, ligaments, muscles, and gut tissue. It has also shown neuroprotective properties in models of traumatic brain injury and spinal cord damage. Anti-inflammatory and gastroprotective effects are among the most consistently replicated findings.

Dosing in research contexts: Animal studies typically use doses of 10 mcg/kg body weight. Extrapolating to human equivalents is complex and not straightforward. The peptide is administered subcutaneously or intramuscularly in most research protocols.

Limitations: It is critical to note that the vast majority of BPC-157 research is preclinical. There are very few human trials, and none that meet the standards required for regulatory approval. Claims about human efficacy are therefore speculative and not evidence-based in the clinical sense.

Storage: BPC-157 should be stored as a lyophilised powder at -20°C for long-term storage, or at 2-8°C once reconstituted. See our storage guide for full details.